Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD.

JAMA. 2013 Mar 27;309(12):1260-7. doi: 10.1001/jama.2013.2290.

PMID:
23532242
2.

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ.

Lancet Respir Med. 2014 Dec;2(12):988-96. doi: 10.1016/S2213-2600(14)70213-9. Epub 2014 Oct 14. Erratum in: Lancet Respir Med. 2015 Apr;3(4):e15.

PMID:
25458200
3.

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG.

JAMA. 2013 Mar 27;309(12):1251-9. doi: 10.1001/jama.2013.1937.

PMID:
23532241
4.

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.

Burr LD, Rogers GB, Chen AC, Hamilton BR, Pool GF, Taylor SL, Venter D, Bowler SD, Biga S, McGuckin MA.

Ann Am Thorac Soc. 2016 Oct;13(10):1697-1703.

PMID:
27464029
5.

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I; ORBIT-2 investigators.

Thorax. 2013 Sep;68(9):812-7. doi: 10.1136/thoraxjnl-2013-203207. Epub 2013 May 16.

6.

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F; AZ0004 Azithromycin Study Group.

JAMA. 2010 May 5;303(17):1707-15. doi: 10.1001/jama.2010.563.

PMID:
20442386
7.
8.

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T.

Lancet. 2012 Aug 18;380(9842):660-7. doi: 10.1016/S0140-6736(12)60953-2.

PMID:
22901887
9.

Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R.

Ann Pharmacother. 2005 Jan;39(1):39-44. Epub 2004 Nov 23.

PMID:
15562142
10.

A pilot study of low-dose erythromycin in bronchiectasis.

Tsang KW, Ho PI, Chan KN, Ip MS, Lam WK, Ho CS, Yuen KY, Ooi GC, Amitani R, Tanaka E.

Eur Respir J. 1999 Feb;13(2):361-4.

11.

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.

Serisier DJ, Martin ML.

Respir Med. 2011 Jun;105(6):946-9. doi: 10.1016/j.rmed.2011.01.009. Epub 2011 Mar 1.

12.

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW 3rd; Macrolide Study Group.

JAMA. 2003 Oct 1;290(13):1749-56.

PMID:
14519709
13.

Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.

Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ.

Thorax. 2013 Aug;68(8):731-7. doi: 10.1136/thoraxjnl-2012-203105. Epub 2013 Apr 6.

PMID:
23564400
14.

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group.

JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.

15.

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.

Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Döring G, von der Hardt H.

Pediatr Pulmonol. 1998 Feb;25(2):88-92.

PMID:
9516091
16.

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.

BMC Pediatr. 2012 Aug 14;12:122.

17.

Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Welsh EJ, Evans DJ, Fowler SJ, Spencer S.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010337. doi: 10.1002/14651858.CD010337.pub2. Review.

PMID:
26171905
18.

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.

Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB.

Lancet Respir Med. 2013 Oct;1(8):610-620. doi: 10.1016/S2213-2600(13)70185-1. Epub 2013 Sep 17. Erratum in: Lancet Respir Med. 2015 Aug;3(8):e29.

PMID:
24461664
19.

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.

Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJ, O'Dochartaigh C, van Haren EH, Vidal LO, Welte T, Fox HG, Wu J, Charlton B; B-305 Study Investigators.

Thorax. 2014 Dec;69(12):1073-9. doi: 10.1136/thoraxjnl-2014-205587. Epub 2014 Sep 21.

PMID:
25246664
20.

Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.

Yang JW, Fan LC, Lu HW, Miao XY, Mao B, Xu JF.

Clin Respir J. 2016 Nov;10(6):731-739. doi: 10.1111/crj.12278. Epub 2015 Mar 2. Review.

PMID:
25620629

Supplemental Content

Support Center